28.11.2023 07:30 AM GMT
Live Online Course
Event Host
Paul Craddy & Graham Foxon
Event Description

Treatments for Orphan and Rare Disease offer attractive business opportunities to pharma, but the path to patient access is paved with many challenges. To optimise market access, companies need to carefully plan and execute their market access development strategy, as well as the evidence base and the value proposition.

This 1-day face-to-face course in Brussels discusses the critical success factors and many real-life cases.

You will learn:

  • Understand the business opportunities & challenges for Orphan/Rare Disease drugs
  • Guidelines for developing a global market access strategy
  • Learn which evidence will be needed for optimal access
  • Discover the do’s & don’ts of Managed Entry Agreements and Early Access Programs
  • Learn the Critical Success Factors of building a value proposition for your Orphan Drugs /Rare Disease treatment

Why should you attend?

Graham and Paul have gained broad and deep expertise in developing and implementing market access and pricing strategies, also specifically for Orphan and Rare diseases. They have a knack for explaining complex matters in a clear and easy to comprehend way. Both are regular guest lecturers at universities and business schools, as well as speakers at international events and conferences.

Dates & Locations

There are multiple dates available, all delivered as “live online” courses. Once you click through to the registration page, you can choose from:

  • 28th November 2023
  • 24th April 2023
  • 7th November 2024
Register now

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.